Search - tctmd.com

Displaying 221 - 240 of 495

Sort: Relevancy | Date

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Daily News

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

Michael O'Riordan

August 21, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Caitlin E. Cox

May 30, 2018

News Industry News

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

May 24, 2018

News Industry News

Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease

May 23, 2018

News Daily News

Left or Right? Transradial PCI Outcomes Generally Similar Regardless of Side Chosen

Yael L. Maxwell

May 21, 2018

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Shelley Wood

May 04, 2018

News Conference News SCAI 2018

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

L.A. McKeown

April 26, 2018

News Conference News SCAI 2018

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

L.A. McKeown

April 26, 2018

News Industry News

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

April 24, 2018

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

News Conference News ACC 2018

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

Michael O'Riordan

March 11, 2018

News Conference News CRT 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Michael O'Riordan

March 06, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

Shelley Wood

March 01, 2018

Advertisement

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease

Left or Right? Transradial PCI Outcomes Generally Similar Regardless of Side Chosen

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Uncomplicated TLR After PCI Linked With Worse Mortality

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

TCTMD’s Top 10 Most Popular Stories for February 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content